Somatrogon

Phase 3Small molecule

Pfizer

Somatrogon is one of 62 small molecule programs targeting Small for gestational age. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Small for Gestational AgeActive, not recruiting

Growth Hormone DeficiencyActive, not recruiting

GrowthActive, not recruiting

Small for Gestational AgePhase 3

Active, not recruiting

Growth Hormone DeficiencyPreclinical

Active, not recruiting

GrowthPhase 3

Active, not recruiting

Competition

Competitive Landscape

364 competitors in Growth

#DrugCompanyPhaseTrials

Somatrogon

Pfizer

Phase 3

1 2

Genotropin

EMD Serono

Preclinical

35 3

Zolymbus

AbbVie

Preclinical

1 4

Lenvima

Eisai

Preclinical

1 5

Aricept

Eisai

Preclinical

1 6

Zyloprim

Alnylam Pharmaceuticals

Preclinical

1 7

Somavaratan

Glucophage

2 9

Prilosec

DDexcel Pharma Technologies Ltd.

Preclinical

1 10

Accutane

CConrado Roberto Hoffmann Filho

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Phase 3Recruiting

Small for Gestational Age

NCT07226089

Q3 2028

Recruiting

Dwarfism, Pituitary

NCT06587035

Clinical

Trials by Indication[1]

Drug1 trial

A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations

Completed·OOPKO Health, Inc.·Phase 1·NCT03810664·49 enrolled

Small for gestational age1 trial

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Recruiting·RRabin Medical Center·Phase 3·NCT07226089·254 enrolled

Growth1 trial

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Completed· Pfizer logo

Pfizer·Phase 3·NCT03831880·87 enrolled

Dwarfism, Pituitary1 trial

A Multicenter, Non-interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care in India

Recruiting· Pfizer logo

Pfizer··NCT06587035·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Somatrogon. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Somatrogon compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Somatrogon. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Somatrogon

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Q3 2028

Trials by Indication[1]

Drug1 trial

Small for gestational age1 trial

Growth1 trial

Dwarfism, Pituitary1 trial

References

Drug Info

Quick Facts

Related News